-
妊娠期甲状腺功能异常增加母儿并发症风险,影响子代智力发育[1-2],孕前和妊娠早期进行甲状腺疾病筛查有助于改善妊娠结局。妊娠期由于雌激素和人绒毛膜促性腺激素(human chorionic gonadotropin, hCG)等分泌增加、孕妇自身免疫功能状态改变及不同地区碘营养背景、种族、妊娠周期、地理位置、检测方法等不同,甲状腺功能异常的诊断标准需要进行相应修正。目前认为应建立不同地区或诊疗机构的妊娠期特异、方法特异的妊娠期促甲状腺激素(thyroid stimulating hormone,TSH)及游离甲状腺素(free thyroxine,FT4)第2.5~97.5百分位数作为参考范围。在无法取得上述参考范围时则推荐妊娠早期以4 μIU/mL作为TSH水平参考范围上限值;FT4水平参考范围下限值在妊娠早期不应低于普通人群的参考范围下限,妊娠中期较普通人群下降约13%,妊娠晚期下降约21%[3]。但对于上述参考范围的界定是否符合中国人群有待进一步临床验证[4]。本研究收集安徽医科大学附属妇幼保健院分娩产妇的孕期甲状腺功能检测水平进行分析,为妊娠期甲状腺疾病的临床诊治提供资料。
-
不同妊娠时期产妇TSH、FT4水平间差异均有统计学意义(P < 0.01),其中T3期TSH均明显高于T1、T2期(P < 0.01),FT4则明显低于T1、T2期(P < 0.01),T2期FT4亦明显低于T1期(P < 0.01)(见表 1)。
分组 n TSH/(μIU/mL) FT4/(ng/dL) T1期组 431 1.78±1.01 0.84±0.18 T2期组 933 1.83±0.95 0.60±0.10** T3期组 537 2.12±1.32**## 0.52±0.09**## F — 15.76 854.59 P — < 0.01 < 0.01 MS组内 — 1.166 0.015 q检验: 与T1期组比较**P < 0.01;与T2期组比较##P < 0.01 表 1 不同妊娠时期TSH、FT4水平(x±s)
-
按照具体孕周将产妇分为妊娠0~11+6周、12~19+6周、20~27+6周、28~35+6周、≥36周共5组,结果显示,不同孕周产妇TSH和FT4水平间差异均有统计学意义(P < 0.01)。其中妊娠12~19+6周时TSH最低(P < 0.05),此后随孕周增加,TSH水平呈上升趋势(P < 0.05),在妊娠≥36周时TSH最高(P < 0.05);FT4则在妊娠0~11+6周时水平最高(P < 0.05),此后随孕周增加,趋于平稳(P>0.05)(见表 2)。
孕周 n TSH/(μIU/mL) FT4/(ng/dL) 0~11+6 431 1.78±1.01 0.84±0.18 12~19+6 469 1.67±0.95* 0.66±0.09* 20~27+6 464 1.99±0.93*# 0.54±0.08* 28~35+6 441 1.92±0.96*# 0.52±0.10* ≥36 96 3.03±2.14*#△▲ 0.53±0.09* F — 35.45 549.12 P — < 0.01 < 0.01 MS组内 — 1.109 0.013 q检验: 与0~11+6周组比较*P < 0.05;与12~19+6周组比较#P < 0.05;与20~27+6周组比较△P < 0.05;与28~35+6周组比较▲P < 0.05 表 2 不同孕周产妇的TSH、FT4水平比较(x±s)
妊娠期不同孕周的TSH和FT4水平研究
Study on the levels of TSH and FT4 in different gestational weeks of normal pregnancy
-
摘要:
目的探讨正常妊娠不同孕周血清促甲状腺激素(TSH)、游离甲状腺素(FT4)水平的参考值范围。 方法回顾性收集孕期行甲状腺筛查检测产妇1 901人次,按检测时孕周分为妊娠早期(T1期,≤11+6周)、妊娠中期(T2期,12~27+6周)、妊娠晚期(T3期,≥28周)。并按照具体孕周将产妇分为妊娠0~11+6周、12~19+6周、20~27+6周、28~35+6周、≥36周共5组。建立妊娠不同时期、不同具体孕周甲状腺功能指标的血清学参考值范围。 结果不同妊娠时期产妇TSH、FT4水平间差异均有统计学意义(P < 0.01),其中T3期TSH为(2.12±1.32)μU/mL,均明显高于T1、T2期的(1.78±1.01)μU/mL、(1.83±0.95)μU/mL(P < 0.01),TSH参考范围上限值在T1、T2、T3期分别为3.76、3.79、4.71 μU/mL;T3期FT4为(0.52±0.09)ng/dL,则明显低于T1、T2期的(0.84±0.18)ng/mL、(0.60±0.10)ng/dL(P < 0.01),T2期FT4亦明显低于T1期(P < 0.01)。不同孕周产妇TSH和FT4水平间差异亦均有统计学意义(P < 0.01)。其中妊娠12~19+6周时TSH最低(P < 0.05),此后随孕周增加,TSH水平呈上升趋势(P < 0.05),在妊娠≥36周时TSH最高(P < 0.05);FT4则在妊娠0~11+6周时水平最高(P < 0.05),此后均低于0~11+6周(P < 0.05),随孕周增加,趋于平稳(P>0.05)。 结论妊娠不同时期TSH、FT4参考范围不同,建立孕周特异和方法特异的妊娠不同时期及具体孕周的参考值有利于指导临床妊娠期甲状腺疾病的筛查和处理。 Abstract:ObjectiveTo explore the reference value of serum thyroid stimulating hormone(TSH) and free thyroxine(FT4) levels in different gestational weeks of normal pregnancy. MethodsA total of 1 901 pregnant women with screening thyroid during pregnancy were retrospectively analyzed, and divided into the first trimester(T1, ≤11+6 weeks), second trimester(T2, 12-27+6 weeks) and third trimester(T3, ≥28 weeks) according to the gestational age at the time of detection.According to the specific gestational weeks, the puerpera were divided into the 0-11+6 weeks gestation group, 12-19+6 weeks gestation group, 20-27+6 weeks gestation group, 28~35+6 weeks gestation group and ≥36 weeks gestation group.The serological reference range of thyroid function indexes in different gestational weeks and periods of pregnancy were established. ResultsThe differences of the levels of TSH and FT4 among different stages of pregnancy were statistically significant(P < 0.01), the TSH in T3 stage was (2.12±1.32) μU/mL, which was significantly higher than that in T1 and T2 stages[(1.78±1.01)μU/mL and (1.83±0.95)μU/mL] (P < 0.01).The upper limits of TSH reference range were 3.76, 3.79 and 4.71 μU/mL in T1, T2 and T3 stages, respectively.The FT4 of T3 stage was (0.52±0.09)ng/dL, which was significantly lower than that of T1 and T2 stages[(0.84±0.18)ng/dL and (0.60±0.10]ng/dL(P < 0.01).The FT4 of T2 stage was also significantly lower than that of T1 (P < 0.01).The differences of the TSH and FT4 levels among different gestational weeks were statistically significant(P < 0.01).The TSH level was the lowest at 12-19+6 weeks of gestation(P < 0.05), then increased with the increase of gestational age(P < 0.05), and the TSH level was the highest at ≥36 weeks of gestation(P < 0.05).The level of FT4 was the highest at 0-11+6 weeks of gestation(P < 0.05), lower than that at 0-11+6 weeks of gestation(P < 0.05), and tended to be stable with the increase of gestational age(P>0.05). ConclusionsThe reference ranges of TSH and FT4 are different in different stages of pregnancy.The establishment of gestational age specific and method specific reference values in different stages of pregnancy and specific gestational age is helpful to guide the screening and management of thyroid diseases during pregnancy. -
Key words:
- pregnancy /
- thyroid stimulating hormone /
- free thyroxine
-
表 1 不同妊娠时期TSH、FT4水平(x±s)
分组 n TSH/(μIU/mL) FT4/(ng/dL) T1期组 431 1.78±1.01 0.84±0.18 T2期组 933 1.83±0.95 0.60±0.10** T3期组 537 2.12±1.32**## 0.52±0.09**## F — 15.76 854.59 P — < 0.01 < 0.01 MS组内 — 1.166 0.015 q检验: 与T1期组比较**P < 0.01;与T2期组比较##P < 0.01 表 2 不同孕周产妇的TSH、FT4水平比较(x±s)
孕周 n TSH/(μIU/mL) FT4/(ng/dL) 0~11+6 431 1.78±1.01 0.84±0.18 12~19+6 469 1.67±0.95* 0.66±0.09* 20~27+6 464 1.99±0.93*# 0.54±0.08* 28~35+6 441 1.92±0.96*# 0.52±0.10* ≥36 96 3.03±2.14*#△▲ 0.53±0.09* F — 35.45 549.12 P — < 0.01 < 0.01 MS组内 — 1.109 0.013 q检验: 与0~11+6周组比较*P < 0.05;与12~19+6周组比较#P < 0.05;与20~27+6周组比较△P < 0.05;与28~35+6周组比较▲P < 0.05 -
[1] 陈红波, 亓立红, 谢少云. 孕早期促甲状腺素和β-人绒毛膜促性腺激素联合预测子痫前期的应用价值[J]. 中华生殖与避孕杂志, 2018, 38(11): 893. [2] ALEXANDER EK, PEARCE EN, BRENT GA, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum[J]. Thyroid, 2017, 27(3): 315. doi: 10.1089/thy.2016.0457 [3] GAO X, LI Y, LI J, et al. Gestational TSH and FT4 reference intervals in Chinese women: a systematic review and meta-analysis[J]. Front Endocrinol (Lausanne), 2018, 9: 432. doi: 10.3389/fendo.2018.00432 [4] 单忠艳. 最新ATA妊娠甲状腺疾病诊治指南中的中国证据[J]. 中华医学信息导报, 2017, 32(9): 11. doi: 10.3760/cma.j.issn.1000-8039.2017.09.006 [5] 赵雅菲, 申庆文. 亚临床甲状腺疾病与稽留流产的相关性研究[J]. 蚌埠医学院学报, 2017, 42(11): 1449. [6] NAZARPOUR S, RAMEZANI TF, SIMBAR M, et al. Thyroid dysfunction and pregnancy outcomes[J]. Iran J Reprod Med, 2015, 13(7): 387. [7] 周玮, 黄婷. 妊娠期甲状腺疾病监测与处理[J]. 中国实用妇科与产科杂志, 2017, 33(3): 263. [8] 黄璐, 罗丹, 王利民, 等. 成都地区妊娠期特异性甲状腺激素水平参考值范围的探讨及临床分析[J]. 现代妇产科进展, 2016, 25(4): 269. [9] 卫蔷, 张力, 刘兴会, 等. 妊娠不同时期甲状腺功能指标参考值的临床分析[J]. 中华妇产科杂志, 2018, 53(5): 299. doi: 10.3760/cma.j.issn.0529-567x.2018.05.003 [10] 彭晶晶, 陶峰, 陈红波, 等. 妊娠期甲状腺生理及特异性参考值范围建立的现状[J]. 临床与病理杂志, 2020, 40(4): 1023. [11] 贺淑巍, 张晶晶, 王旭, 等. 妊娠期甲状腺激素相关指标的参考区间研究[J]. 现代妇产科进展, 2018, 27(8): 608. [12] 陈瑶, 韩艳, 黄锟, 等. 马鞍山育龄妇女孕早期和孕中期甲状腺激素参考值队列研究[J]. 中国公共卫生, 2018, 34(4): 469. [13] 杜静, 蔺莉, 李智, 等. 不同促甲状腺激素切点值对妊娠早期亚临床甲状腺功能减退症诊断的影响[J]. 中华医学杂志, 2019, 99(2): 120. [14] 陈赟, 马维青, 陶存武. 合肥市城区居民尿碘水平与甲状腺功能相关性的临床分析[J]. 中华地方病学杂志, 2018, 37(4): 334. [15] 唐胜利, 吴君霞. 246例合肥市妊娠中期妇女尿碘水平的分析[J]. 临床输血与检验, 2017, 19(5): 467.